The Internalization Pathways of Liposomes, PLGA, and Magnetic Nanoparticles in Neutrophils
Abstract
:1. Introduction
2. Materials and Methods
2.1. Nanoparticles’ Synthesis
2.2. Animals and Tumor Model
2.3. Neutrophils Isolation from the Blood of Tumor-Bearing Mice
2.4. Study of Intracellular Nanoparticles’ Localization
2.4.1. Immunocytochemical Staining
2.4.2. Transmission Electron Microscopy
2.5. Dynamics of Nanoparticles’ Interaction with Neutrophils In Vitro
2.6. Endocytosis Mechanisms’ Investigation by Inhibitory Assay
2.7. The Role of Neutrophil Receptors and Serum Factors during the Nanoparticles’ Uptake In Vitro
2.8. Statistics
3. Results
3.1. Nanoparticles’ Accumulation in Neutrophils In Vitro
3.2. Nanoparticle Internalization Mechanisms in Neutrophils In Vitro
3.3. The Role of Plasma Factors and Neutrophil Receptors in Nanoparticle Uptake In Vitro
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Farjadian, F.; Ghasemi, A.; Gohari, O.; Roointan, A.; Karimi, M.; Hamblin, M.R. Nanopharmaceuticals and nanomedicines currently on the market: Challenges and opportunities. Nanomedicine 2019, 14, 93–126. [Google Scholar] [CrossRef] [PubMed]
- Danhier, F. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? J. Control Release 2016, 244, 108–121. [Google Scholar] [CrossRef] [PubMed]
- Wilhelm, S.; Tavares, A.J.; Dai, Q.; Ohta, S.; Audet, J.; Dvorak, H.F.; Chan, W.C.W. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 2016, 1, 16014. [Google Scholar] [CrossRef]
- Chan, W.-J.; Li, H.; Dehestani, S. Cell-based drug-delivery systems: A possible solution to improve nanomedicine for cancer treatment? Nanomedicine 2022, 17, 349–352. [Google Scholar] [CrossRef] [PubMed]
- Choi, A.; Javius-Jones, K.; Hong, S.; Park, H. Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform. Int. J. Nanomed. 2023, 18, 509–525. [Google Scholar] [CrossRef]
- Timin, A.S.; Litvak, M.M.; Gorin, D.A.; Atochina-Vasserman, E.N.; Atochin, D.N.; Sukhorukov, G.B. Cell-Based Drug Delivery and Use of Nano-and Microcarriers for Cell Functionalization. Adv. Healthc. Mater. 2018, 7, 1700818. [Google Scholar] [CrossRef]
- Petri, B.; Phillipson, M.; Kubes, P. The Physiology of Leukocyte Recruitment: An In Vivo Perspective. J. Immunol. 2008, 180, 6439–6446. [Google Scholar] [CrossRef]
- Lin, M.H.; Lin, C.F.; Yang, S.C.; Hung, C.F.; Fang, J.Y. The Interplay between Nanoparticles and Neutrophils. J. Biomed. Nanotechnol. 2018, 14, 66–85. [Google Scholar] [CrossRef]
- Pleskova, S.N.; Mikheeva, E.R.; Razumkova, E.V.; Gornostaeva, E.E. The Effect of Magnetite Nanoparticles and Bacteria on the Activity of NADPH-Oxidase and Myeloperoxidase in Neutrophils of Human Blood. Cell Tissue Biol. 2018, 12, 120–126. [Google Scholar] [CrossRef]
- Pleskova, S.N.; Mikheeva, E.R.; Gornostaeva, E.E. The interaction between human blood neutrophil granulocytes and quantum dots. Micron 2018, 105, 82–92. [Google Scholar] [CrossRef]
- Pleskova, S.N.; Kriukov, R.N.; Gorshkova, E.N.; Boryakov, A.V. Characteristics of quantum dots phagocytosis by neutrophil granulocytes. Heliyon 2019, 5, e01439. [Google Scholar] [CrossRef] [PubMed]
- Paul, D.; Achouri, S.; Yoon, Y.Z.; Herre, J.; Bryant, C.E.; Cicuta, P. Phagocytosis dynamics depends on target shape. Biophys. J. 2013, 105, 1143–1150. [Google Scholar] [CrossRef] [PubMed]
- Oh, N.; Park, J.H. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int. J. Nanomed. 2014, 9 (Suppl. S1), 51–63. [Google Scholar]
- Sousa de Almeida, M.; Susnik, E.; Drasler, B.; Taladriz-Blanco, P.; Petri-Fink, A.; Rothen-Rutishauser, B. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine. Chem. Soc. Rev. 2021, 50, 5397–5434. [Google Scholar] [CrossRef]
- Gao, H.; Shi, W.; Freund, L.B. From The Cover: Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 2005, 102, 9469–9474. [Google Scholar] [CrossRef] [PubMed]
- Niaz, S.; Forbes, B.; Raimi-Abraham, B.T. Exploiting Endocytosis for Non-Spherical Nanoparticle Cellular Uptake. Nanomanufacturing 2022, 2, 1–16. [Google Scholar] [CrossRef]
- Canton, J. Macropinocytosis: New Insights Into Its Underappreciated Role in Innate Immune Cell Surveillance. Front. Immunol. 2018, 9, 2286. [Google Scholar] [CrossRef] [PubMed]
- Xie, X.; Liao, J.; Shao, X.; Li, Q.; Lin, Y. The Effect of shape on Cellular Uptake of Gold Nanoparticles in the forms of Stars, Rods, and Triangles. Sci. Rep. 2017, 7, 3827. [Google Scholar] [CrossRef]
- Ding, L.; Yao, C.; Yin, X.; Li, C.; Huang, Y.; Wu, M.; Wang, B.; Guo, X.; Wang, Y.; Wu, M. Size, Shape, and Protein Corona Determine Cellular Uptake and Removal Mechanisms of Gold Nanoparticles. Small 2018, 14, e1801451. [Google Scholar] [CrossRef]
- Manzanares, D.; Ceña, V. Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell. Pharmaceutics 2020, 12, 371. [Google Scholar] [CrossRef]
- Wang, T.; Wang, L.; Li, X.; Hu, X.; Han, Y.; Luo, Y.; Wang, Z.; Li, Q.; Aldalbahi, A.; Wang, L.; et al. Size-Dependent Regulation of Intracellular Trafficking of Polystyrene Nanoparticle-Based Drug-Delivery Systems. ACS Appl. Mater. Interfaces 2017, 9, 18619–18625. [Google Scholar] [CrossRef]
- Platel, A.; Carpentier, R.; Becart, E.; Mordacq, G.; Betbeder, D.; Nesslany, F. Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis. J. Appl. Toxicol. 2016, 36, 434–444. [Google Scholar] [CrossRef] [PubMed]
- Jose, A.; Labala, S.; Venuganti, V.V. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer. J. Drug Target. 2017, 25, 330–341. [Google Scholar] [CrossRef] [PubMed]
- Lu, M.; Zhao, X.; Xing, H.; Xun, Z.; Zhu, S.; Lang, L.; Yang, T.; Cai, C.; Wang, D.; Ding, P. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA. Int. J. Pharm. 2018, 550, 100–113. [Google Scholar] [CrossRef] [PubMed]
- Liu, Q.; Huang, J.; Feng, Q.; Zhang, T.; Chen, X.; Li, X.; Liu, X.; Li, H.; Zhong, Z.; Xiao, K. Multi-Modal Visualization of Uptake and Distribution of Iron Oxide Nanoparticles in Macrophages, Cancer Cells, and Xenograft Models. J. Biomed. Nanotechnol. 2019, 15, 1801–1811. [Google Scholar] [CrossRef] [PubMed]
- Petters, C.; Dringen, R. Accumulation of iron oxide nanoparticles by cultured primary neurons. Neurochem. Int. 2015, 81, 1–9. [Google Scholar] [CrossRef]
- Calero, M.; Chiappi, M.; Lazaro-Carrillo, A.; Rodriguez, M.J.; Chichon, F.J.; Crosbie-Staunton, K.; Prina-Mello, A.; Volkov, Y.; Villanueva, A.; Carrascosa, J.L. Characterization of interaction of magnetic nanoparticles with breast cancer cells. J. Nanobiotechnol. 2015, 13, 16. [Google Scholar] [CrossRef]
- Bisso, P.W.; Gaglione, S.; Guimaraes, P.P.G.; Mitchell, M.J.; Langer, R. Nanomaterial interactions with human neutrophils. ACS Biomater. Sci. Eng. 2018, 4, 4255–4265. [Google Scholar] [CrossRef]
- Safari, H.; Kelley, W.J.; Saito, E.; Kaczorowski, N.; Carethers, L.; Shea, L.D.; Eniola-Adefeso, O. Neutrophils preferentially phagocytose elongated particles-an opportunity for selective targeting in acute inflammatory diseases. Sci. Adv. 2020, 6, eaba1474. [Google Scholar] [CrossRef]
- Vishnevskiy, D.A.; Garanina, A.S.; Chernysheva, A.A.; Chekhonin, V.P.; Naumenko, V.A. Neutrophil and Nanoparticles De-livery to Tumor: Is It Going to Carry That Weight? Adv. Healthc. Mater. 2021, 10, e2002071. [Google Scholar] [CrossRef]
- Tan, X.; Luo, M.; Liu, A.P. Clathrin-mediated endocytosis regulates fMLP-mediated neutrophil polarization. Heliyon 2018, 4, e00819. [Google Scholar] [CrossRef] [PubMed]
- Fabbri, M.; Meglio, S.D.; Gagliani, M.C.; Consonni, E.; Molteni, R.; Bender, J.R.; Tacchetti, C.; Pardi, R. Dynamic Partitioning into Lipid Rafts Controls the Endo-Exocytic Cycle of the αL/β 2 Integrin, LFA-1, during Leukocyte Chemotaxis. Mol. Biol. Cell 2005, 16, 5793–5803. [Google Scholar] [CrossRef] [PubMed]
- Zhao, H.; Gulesserian, S.; Malinao, M.C.; Ganesan, S.K.; Song, J.; Chang, M.S.; Williams, M.M.; Zeng, Z.; Mattie, M.; Mendelsohn, B.A.; et al. A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own Demise. Mol. Cancer Ther. 2017, 16, 1866–1876. [Google Scholar] [CrossRef]
- Garanina, A.S.; Vishnevskiy, D.A.; Chernysheva, A.A.; Valikhov, M.P.; Malinovskaya, J.A.; Lazareva, P.A.; Semkina, A.S.; Abakumov, M.A.; Naumenko, V.A. Neutrophil as a Carrier for Cancer Nanotherapeutics: A Comparative Study of Liposome, PLGA, and Magnetic Nanoparticles Delivery to Tumors. Pharmaceuticals 2023, 16, 1564. [Google Scholar] [CrossRef]
- Hosseinalizadeh, H.; Mahmoodpour, M.; Bahabadi, Z.R.; Hamblin, M.R.; Mirzaei, H. Neutrophil mediated drug delivery for targeted glioblastoma therapy: A comprehensive review. Biomed. Pharmacother. 2022, 156, 113841. [Google Scholar] [CrossRef]
- Lim, Y.W.; Tan, W.S.; Ho, K.L.; Mariatulqabtiah, A.R.; Abu Kasim, N.H.; Abd Rahman, N.; Wong, T.W.; Chee, C.F. Challenges and Complications of Poly(lactic-co-glycolic acid)-Based Long-Acting Drug Product Development. Pharmaceutics 2022, 14, 614. [Google Scholar] [CrossRef]
- Naumenko, V.A.; Vlasova, K.Y.; Garanina, A.S.; Melnikov, P.A.; Potashnikova, D.M.; Vishnevskiy, D.A.; Vodopyanov, S.S.; Chekhonin, V.P.; Abakumov, M.A.; Majouga, A.G. Extravasating Neutrophils Open Vascular Barrier and Improve Liposomes Delivery to Tumors. ACS Nano 2019, 13, 12599–12612. [Google Scholar] [CrossRef]
- Zulkefli, K.L.; Houghton, F.J.; Gosavi, P.; Gleeson, P.A. A role for Rab11 in the homeostasis of the endosome-lysosomal pathway. Exp. Cell Res. 2019, 380, 55–68. [Google Scholar] [CrossRef] [PubMed]
- Dutta, D.; Williamson, C.D.; Cole, N.B.; Donaldson, J.G. Pitstop 2 Is a Potent Inhibitor of Clathrin-Independent Endocytosis. PLoS ONE 2012, 7, e45799. [Google Scholar] [CrossRef]
- Liashkovich, I.; Pasrednik, D.; Prystopiuk, V.; Rosso, G.; Oberleithner, H.; Shahin, V. Clathrin inhibitor Pitstop-2 disrupts the nuclear pore complex permeability barrier. Sci. Rep. 2015, 5, 9994. [Google Scholar] [CrossRef]
- Koivusalo, M.; Welch, C.; Hayashi, H.; Scott, C.C.; Kim, M.; Alexander, T.; Touret, N.; Hahn, K.M.; Grinstein, S. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J. Cell Biol. 2010, 188, 547–563. [Google Scholar] [CrossRef] [PubMed]
- Murray, S.; Subramanian, S.; Bourdette, D.N.; Jones, R.E. Simplified method of identifying severe combined immunodeficient (SCID) mice versus non-SCID mice by flow cytometric analysis of peripheral blood. Cytometry 1998, 32, 274–279. [Google Scholar] [CrossRef]
- Thelen, T.; Hao, Y.; Medeiros, A.I.; Curtis, J.L.; Serezani, C.H.; Kobzik, L.; Harris, L.H.; Aronoff, D.M. The class A scavenger receptor, macrophage receptor with collagenous structure, is the major phagocytic receptor for Clostridium sordellii expressed by human decidual macrophages. J. Immunol. 2010, 185, 4328–4335. [Google Scholar] [CrossRef]
- Cotter, M.J.; Zaiss, A.K.; Muruve, D.A. Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1. J. Virol. 2005, 79, 14622–14631. [Google Scholar] [CrossRef]
- Nagai, N.; Ogata, F.; Ishii, M.; Fukuoka, Y.; Otake, H.; Nakazawa, Y.; Kawasaki, N. Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles. Int. J. Mol. Sci. 2018, 19, 2138. [Google Scholar] [CrossRef]
- Lira-Nogueira, M.C.B.; Gibson, V.P.; Nicolas, V.; Santos-Magalhães, N.S.; Vauthier, C. Defining Endocytic Pathways of Fucoidan-Coated PIBCA Nanoparticles from the Design of their Surface Architecture. Pharm. Res. 2022, 39, 1135–1150. [Google Scholar] [CrossRef] [PubMed]
- Portilla, Y.; Mulens-Arias, V.; Paradela, A.; Ramos-Fernández, A.; Pérez-Yagüe, S.; Morales, M.P.; Barber, D.F. The surface coating of iron oxide nanoparticles drives their intracellular trafficking and degradation in endolysosomes differently depending on the cell type. Biomaterials 2022, 281, 121365. [Google Scholar] [CrossRef]
- Svitkova, B.; Zavisova, V.; Nemethova, V.; Koneracka, M.; Kretova, M.; Razga, F.; Ursinyova, M.; Gabelova, A. Differences in surface chemistry of iron oxide nanoparticles result in different routes of internalization. Beilstein J. Nanotechnol. 2021, 12, 270–281. [Google Scholar] [CrossRef]
- Gandek, T.B.; van der Koog, L.; Nagelkerke, A. A Comparison of Cellular Uptake Mechanisms, Delivery Efficacy, and Intracellular Fate between Liposomes and Extracellular Vesicles. Adv. Healthc. Mater. 2023, 12, e2300319. [Google Scholar] [CrossRef]
- Suk, J.S.; Xu, Q.; Kim, N.; Hanes, J.; Ensign, L.M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 2016, 99 Pt A, 28–51. [Google Scholar] [CrossRef]
- Li, L.; Qian, Y.; Sun, L.; Han, F.Y.; Zhang, R.; Wang, P.Y.; Xu, Z.P. Albumin-stabilized layered double hydroxide nanoparticles synergized combination chemotherapy for colorectal cancer treatment. Nanomedicine 2021, 34, 102369. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.; Sun, B.; Sun, L.; Niu, X.; Li, L.; Xu, Z.P. “Trojan horse” nanoparticle-delivered cancer cell membrane vaccines to enhance cancer immunotherapy by overcoming immune-escape. Biomater. Sci. 2023, 11, 2020–2032. [Google Scholar] [CrossRef] [PubMed]
- Mimansa; Jamwal, M.; Das, R.; Shanavas, A. High Drug Loading Nanoparticles Stabilized with Autologous Serum Proteins Passively Inhibits Tumor Growth. Biomacromolecules 2022, 23, 5065–5073. [Google Scholar] [CrossRef] [PubMed]
- Taban, Q.; Mumtaz, P.T.; Masoodi, K.Z.; Haq, E.; Ahmad, S.M. Scavenger receptors in host defense: From functional aspects to mode of action. Cell Commun. Signal 2022, 20, 2. [Google Scholar] [CrossRef]
- Yang, Y.; Wang, N.; Zhu, Y.; Lu, Y.; Chen, Q.; Fan, S.; Huang, Q.; Chen, X.; Xia, L.; Wei, Y.; et al. Gold nanoparticles synergize with bacterial lipopolysaccharide to enhance class A scavenger receptor dependent particle uptake in neutrophils and augment neutrophil extracellular traps formation. Ecotoxicol. Environ. Saf. 2021, 211, 111900. [Google Scholar] [CrossRef]
- Wang, R.; Lohray, R.; Chow, E.; Gangupantula, P.; Smith, L.; Draper, R. Selective Uptake of Carboxylated Multi-Walled Carbon Nanotubes by Class A Type 1 Scavenger Receptors and Impaired Phagocytosis in Alveolar Macrophages. Nanomaterials 2020, 10, 2417. [Google Scholar] [CrossRef]
- Huynh, M.T.; Mikoryak, C.; Pantano, P.; Draper, R. Scavenger Receptor A1 Mediates the Uptake of Carboxylated and Pristine Multi-Walled Carbon Nanotubes Coated with Bovine Serum Albumin. Nanomaterials 2021, 11, 539. [Google Scholar] [CrossRef]
- Su, Y.; Gao, J.; Kaur, P.; Wang, Z. Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases. Pharmaceutics 2020, 12, 1222. [Google Scholar] [CrossRef]
- Robertson, J.D.; Ward, J.R.; Avila-Olias, M.; Battaglia, G.; Renshaw, S.A. Targeting Neutrophilic Inflammation Using Polymersome-Mediated Cellular Delivery. J. Immunol. 2017, 198, 3596–3604. [Google Scholar] [CrossRef]
- Wu, M.; Zhang, H.; Tie, C.; Yan, C.; Deng, Z.; Wan, Q.; Liu, X.; Yan, F.; Zheng, H. MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma. Nat. Commun. 2018, 9, 4777. [Google Scholar] [CrossRef]
- Xue, J.; Zhao, Z.; Zhang, L.; Xue, L.; Shen, S.; Wen, Y.; Wei, Z.; Wang, L.; Kong, L.; Sun, H.; et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat. Nanotechnol. 2017, 12, 692–700. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Garanina, A.; Vishnevskiy, D.; Chernysheva, A.; Malinovskaya, J.; Lazareva, P.; Semkina, A.; Abakumov, M.; Naumenko, V. The Internalization Pathways of Liposomes, PLGA, and Magnetic Nanoparticles in Neutrophils. Biomedicines 2024, 12, 2180. https://doi.org/10.3390/biomedicines12102180
Garanina A, Vishnevskiy D, Chernysheva A, Malinovskaya J, Lazareva P, Semkina A, Abakumov M, Naumenko V. The Internalization Pathways of Liposomes, PLGA, and Magnetic Nanoparticles in Neutrophils. Biomedicines. 2024; 12(10):2180. https://doi.org/10.3390/biomedicines12102180
Chicago/Turabian StyleGaranina, Anastasiia, Daniil Vishnevskiy, Anastasia Chernysheva, Julia Malinovskaya, Polina Lazareva, Alevtina Semkina, Maxim Abakumov, and Victor Naumenko. 2024. "The Internalization Pathways of Liposomes, PLGA, and Magnetic Nanoparticles in Neutrophils" Biomedicines 12, no. 10: 2180. https://doi.org/10.3390/biomedicines12102180
APA StyleGaranina, A., Vishnevskiy, D., Chernysheva, A., Malinovskaya, J., Lazareva, P., Semkina, A., Abakumov, M., & Naumenko, V. (2024). The Internalization Pathways of Liposomes, PLGA, and Magnetic Nanoparticles in Neutrophils. Biomedicines, 12(10), 2180. https://doi.org/10.3390/biomedicines12102180